Skip to main navigation Skip to search Skip to main content

The battle against paediatric HIV is far from over – Authors' reply

  • Aaloke Mody
  • , Annette H. Sohn
  • , Collins Iwuji
  • , Rayner K.J. Tan
  • , Francois Venter
  • , Elvin H. Geng
  • Washington University St. Louis
  • The Foundation for AIDS Research
  • Department of Global Health and Infection
  • University of Sussex
  • Africa Health Research Institute
  • University of North Carolina Project-China
  • National University of Singapore
  • University of the Witwatersrand

Research output: Contribution to journalLetterpeer-review

Abstract

We want to thank Philippe Van de Perre and Thorkild Tylleskär for their Correspondence in response to our Seminar on HIV.1 We agree with Van de Perre and Tylleskär that there are substantial barriers on the path to elimination of HIV among children and that they have received less attention. Although new infections among children younger than 15 years have substantially declined, progress along the care continuum persists behind that of adults. As of 2022, only 63% of all children living with HIV knew their HIV status, 57% had started antiretroviral therapy (ART), and 46% had reached viral suppression.2 In addition, despite comprising only 4% of people living with HIV, children account for 13% of all AIDS-related deaths.
Original languageEnglish
Pages (from-to)522-523
Number of pages2
JournalThe Lancet
Volume404
Issue number10452
DOIs
Publication statusPublished - 10 Aug 2024
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'The battle against paediatric HIV is far from over – Authors' reply'. Together they form a unique fingerprint.

Cite this